Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03571529
Other study ID # Bahcesehir University
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 6, 2018
Est. completion date May 31, 2020

Study information

Verified date September 2021
Source Bahçesehir University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The advantage of the EMG-driven exoskeletons is that patient's own muscle power known as Residual Muscle Power is used to move the extremity while many other robotic devices work and drive impaired limb based on machine directed force. However, it is not clear which group of patients are suitable for EMG driven exoskeletons use and there has not been any established treatment protocol. The aims of the study are 1- to investigate the effectiveness of the EMG-driven exoskeleton for hand rehabilitation in patients with acute stroke. 2- to understand which group of the patients may give the best response to the EMG-driven technology and how should be the treatment protocol designed.


Description:

Improving the rehabilitation outcome of the upper extremity in stroke patients has been an ongoing challenge in the rehabilitation field. Up to 85% of stroke survivors experience a certain degree of paresis of the upper limb at the onset and only 20% to 56% of survivors regain complete functional use of the affected upper limb despite the therapeutic interventions in first 3 months . Recovery of upper limb function is generally slower and non-complete. To support and speed up a recovery process, there are many robotic devices currently used in the stroke units. Unlike one-on-one treatment applied by clinicans, robotic devices can provide repetitive, task oriented movements,with greater intensity, stimulating and engaging environment for user, hence alleviating the labour-intensive aspects of hands-on conventional therapy. There are a number of complex robotic devices that have been developed over the last two decades to assist upper arm training in rehabilitation. Using EMG driven exoskeleton, commercially known as the Hand of Hope (HOH), has been shown its efficacy to improve patient's grip and pinch ability, muscle coordination and improve functional daily living tasks in patients even after 3,4,8,10 and 14 years after onset of the stroke. In addition to continuous investigation efforts needed to be spent, there has not been established any treatment protocol using EMG-driven exoskeletons. Since Stroke patients need to be focused on their own residual muscle power, clear indications for EMG-driven exoskeletons i.e., Hand of Hope, need to be established. An investigation designed to highlight all these points will make an important contribution to the therapeutic approach using EMG-driven hand robotics for the hand rehabilitation after stroke.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date May 31, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Having ischemic stroke history within last 4 weeks - Being at the age 18 and older than 18 - Providing a sitting balance during the robot training (maximum 1 hour with preparation time) - Understanding and performing simple commands - Full range of motion in MCP, PIP and DIP - MAS < 3 for finger flexors and extensors - Participants who agree to participate in the study Exclusion Criteria: - Recurrent stroke - Other neurologic or orthopedic problems that may affect to upper extremity functions - Hemispatial neglect (will be diagnosed by Line bisection test and The star cancellation test) - Refused treatment, non-cooperation - MAS = 3 (MAS will be measured every week during the treatment period)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EMG-driven exoskeleton hand robot
Primary Outcome Measurement: 1. Fugl-Meyer Upper Extremity Assessment Secondary Outcome Measurements: Action Research Arm Test Motor Activity Log Data from force and EMG measurement records of HOH robot Grip strength (with hand dynamometer) Range of motion measurements of Wrist, and MCP, PIP and DIP joints of the fingers Manuel muscle testing for wrist and finger muscles. Modify Asworth sclale At the beginning of each robotic treatment session, superficial EMG recording will be taken at relax position ( without muscle contraction) and then during maximal voluntary isometric contraction (MVC) after the patient's hand is placed in the exoskeleton. For both, EMG recording is performed for 7 seconds and Root Mean Square (RMS) is calculated from this record.
Other:
Conventional physiotherapy
Primary Outcome Measurement: 1. Fugl-Meyer Upper Extremity Assessment Secondary Outcome Measurements: Action Research Arm Test Motor Activity Log Data from force and EMG measurement records of HOH robot Grip strength (with hand dynamometer) Range of motion measurements of Wrist, and MCP, PIP and DIP joints of the fingers Manuel muscle testing for wrist and finger muscles. Modify Asworth sclale

Locations

Country Name City State
Turkey Dilber Karagozoglu Coskunsu Istanbul Europe

Sponsors (4)

Lead Sponsor Collaborator
Bahçesehir University Medical Park Hospital Istanbul, Medipol University, Rehab-Robotics Company Limited

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fugl-Meyer Upper Extremity Assessment: Fugl-Meyer assessment was first used in 1975 to assess post-stroke physical performance. 33-item upper extremity subscale of the Fugl-Meyer scale evaluates movements, coordination/speed and pain in the shoulder, elbow, forearm. The highest score for the upper extremity is 66. Change from pre-interventional Fugl-Meyer Upper Extremity score at the end of the 15 sessions intervention that will be performed 5 days in a week at a total of 3 weeks.
Secondary Action Research Arm Test (ARAT) ARAT is a performance test, first described by Lyle in 1982. This test is produced by the upper extremity function test and shows upper extremity function and skill. ARAT consists of four subdivisions and 19 functional items that evaluate grasp, grip, pinch and gross motor movement on the both side. The highest score is 57. Change from pre-interventional ARAT score at the end of the 15 sessions intervention that will be performed 5 days in a week at a total of 3 weeks.
Secondary Motor Activity Log Motor Activity Log is a measure used to assess the amount of use and quality of movement of paretic arms and hands in daily living activities for hemiparetic stroke patients. It consists of 30 items. Change from pre-interventional Motor Activity Log score at the end of the 15 sessions intervention that will be performed 5 days in a week at a total of 3 weeks.
Secondary Manuel muscle testing manuel muscle testing of the flexor and extensor muscles of the wrist and finger Change from pre-interventional Manuel muscle testing scores at the end of the 15 sessions intervention that will be performed 5 days in a week at a total of 3 weeks.
Secondary Range of motion measurement (ROM) Active range of motion of the wrist, MCP, PIP and DIP joints Change from pre-interventional ROMs at the end of the 15 sessions intervention that will be performed 5 days in a week at a total of 3 weeks.
Secondary Force and EMG measurement with the testing device Additional force and EMG measurement with the specially designed testing device Change from pre-interventional force and EMG measurement with the testing device at the end of the 5th session, 10th session and 15 session intervention that will be performed at the last session of each week at a total of 3 weeks.
Secondary hand dynamometer to measure grip strength Change from pre-interventional grip strentgh at the end of the 15 session interventions that will be performed 5 days in a week at a total of 3 weeks.
See also
  Status Clinical Trial Phase
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Enrolling by invitation NCT06074081 - Comparison of 4-weeks of Motor Relearning Program and Mirror Therapy in Improving Upper Limb Motor Function in Stroke Patients. N/A
Terminated NCT04039178 - Efficacy of EMF BCI Based Device on Acute Stroke N/A
Completed NCT04521634 - Glycaemic Variability in Acute Stroke
Completed NCT03477188 - The Effects of Somatosensory and Vestibular Rehabilitation Additional Conventional Therapy on Balance in Patients With Acute Stroke. N/A
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT02677415 - Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular Treatment N/A
Recruiting NCT01541163 - Heart and Ischemic STrOke Relationship studY N/A
Completed NCT01210729 - Mechanical Recanalization With Flow Restoration in Acute Ischemic Stroke Phase 2
Recruiting NCT00785343 - Study of Robot-assisted Arm Therapy for Acute Stroke Patients Phase 1
Completed NCT04779710 - How Does Dysphagia Assessment in Acute Stroke Affect Pneumonia?
Active, not recruiting NCT03635749 - Intensive Medical Therapy for High-risk Intracranial or Extracranial Atherosclerosis Phase 3
Recruiting NCT06149754 - BraiN20® Monitoring in Acute Stroke Undergoing Thrombectomy
Recruiting NCT04491695 - Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke Phase 2/Phase 3
Recruiting NCT04283760 - Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
Recruiting NCT05454397 - A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients
Completed NCT04488692 - Early Functional Training in Acute Stroke Inpatient Ward N/A
Recruiting NCT04214522 - Reliability and Validity of the Kinesthetic and Visual Imagery Questionnaire in Acute Stroke Patients
Not yet recruiting NCT04157231 - Essential Acute Stroke Care in Low Resource Settings: a Pilot studY N/A
Recruiting NCT05469438 - IMAS Optimization and Applicability in an Acute Stroke Setting.